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Abstract Tamarindus indica L. (T. indica) or locally
known as asam jawa belongs to the family of Leguminosae.
The fruit pulp had been reported to have antioxidant
activities and possess hypolipidaemic effects. In this study,
we attempted to investigate the gene expression patterns in
human hepatoma HepG2 cell line in response to treatment
with low concentration of the fruit pulp extracts. Micro-
array analysis using Affymetrix Human Genome 1.0 S.T
arrays was used in the study. Microarray data were vali-
dated using semi-quantitative RT–PCR and real-time
RT–PCR. Amongst the signiﬁcantly up-regulated genes
were those that code for the metallothioneins (MT1M,
MT1F, MT1X) and glutathione S-transferases (GSTA1,
GSTA2, GST02) that are involved in stress response.
APOA4, APOA5, ABCG5 and MTTP genes were also sig-
niﬁcantly regulated that could be linked to hypolipidaemic
activities of the T. indica fruit pulp.
Keywords Tamarindus indica fruit pulp   Gene
expression   Microarray analysis   RT–PCR   HepG2 cells
Introduction
Plants and herbs have been used for years traditionally as
food and for various medicinal purposes. Many of these
plants are excellent sources for polyphenols that are potent
antioxidant compounds which exhibit a wide range of
biological effects as consequences of their antioxidant
properties [7, 21]. Tamarindus indica L. (T. indica)o r
locally known as asam jawa belongs to the family
Leguminosae and grows naturally in many tropical and
subtropical regions. Various parts of the plants are used as
food components and in herbal medicine. The T. indica
fruits have irregular curved pods. When ripe, the pods are
ﬁlled with brown or reddish-brown pulp that coats the
seeds. The pulp has a sweet/sour taste and is widely used as
ﬂavouring in cooking. There are wide differences in fruit
size and ﬂavour in seedling trees. The Indian types have
longer pods with 6–12 seeds, while the West Indian types
have shorter pods, containing only 3–6 seeds. The pulp is
believed to be rich in vitamins and minerals such as niacin
and calcium, respectively [27]. The T. indica fruit pulp is
commonly used in traditional medicine including as a
digestive, laxative, expectorant and an antipyretic agent.
Biochemical analysis in support of the beneﬁcial effects
of the T. indica fruit pulp extracts includes a study by
Martinello et al. [26] who showed that the T. indica fruit
extracts were able to decrease the levels of serum choles-
terol and triglycerides in hypercholesterolaemic hamsters.
The T. indica fruit pulps have also been shown to contain
phenolic antioxidants such as epicatechins [44] that were
able to inhibit low-density lipoprotein (LDL) oxidation in
vitro [45]. Chan et al. [9] had shown that epicatechins from
jasmine green tea were able to reduce serum levels of TG,
and cholesterol in hamsters fed a high-fat diet, but the
hypolipidaemic effects were not through the inhibition of
liver HMGCoA reductase or intestinal ACAT. They further
postulated that the observed hypolipidaemic effects of
epicatechins were probably associated with the inhibition
of absorption of dietary fat, cholesterol or reabsorption of
bile acids [9]. Another group of researchers, Landi
Librandi et al. [22], reported that the fruit pulp extract was
able to modulate the activity of the complement system
when tested both in vitro and in vivo. Scientiﬁc data based
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the pulp extracts are, however, still lacking. Therefore, in
this study, we decided to analyse the global gene expres-
sion in response to low concentration of the fruit pulp
extracts of T. indica in HepG2 cell line, a widely used in
vitro model for human liver hepatocytes.
Materials and methods
Preparation of T. indica fruit pulp extracts
Whole, ripe T. indica fruits were collected from Kedah in
the northern region of Malaysia. The voucher specimen of
the sample with an identiﬁcation number, KLU 45976, was
deposited in the Rimba Ilmu Herbarium, the University of
Malaya. The fruit pulp extracts were prepared as previously
described by Razali et al. [37]. Brieﬂy, the fruit pulp was
separated from the seeds, air-dried and then powdered. The
powdered T. indica fruit pulp (2.5 g) was then placed in a
conical ﬂask and soaked in 50 ml methanol at room tem-
perature for 24 h. The resulting extracts were then ﬁltered,
roto-evaporated and redissolved in 10% DMSO. The
samples were kept at -20C until further analysis.
Cell culture
The human hepatoma cell line HepG2 (ATCC, Manassas,
VA, USA) was grown in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% foetal bovine
serum (Flowlab, Australia), 1% penicillin (Flowlab, Aus-
tralia) and 1% streptomycin (Flowlab, Australia). Cells
were maintained in humidiﬁed air with 5% CO2 at 37C.
Cell viability assay
A cell viability assay was carried out using 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as
described by Mosmann [28], with minor modiﬁcations.
Brieﬂy, HepG2 cells at a density of 5,000 cells per well
were seeded in a 96-well ELISA microplate. The cells were
incubated at 37Ci n5 %C O 2 for 24 h. After 24 h, the pulp
extracts, at various concentrations (100–9,000 lg/ml), were
added into the wells. The cells were left to grow in the
incubator for 48 h. After 48 h, MTT reagent (Merck) was
added, and the mixture was further incubated for 4 h. Next,
the mixture in each well was removed, and formazan
crystals formed were dissolved in 10 ll of 75% isopropa-
nol. Spectrophotometric measurement of the mixture was
performed in a microplate reader (Bio-Rad) at wavelengths
of 570 and 620 nm. A log plot of cell viability (%) against
the concentrations of plant extracts were constructed. From
the plot, a near non-toxic concentration of the extracts was
chosen to study the modiﬁcations of gene expression
patterns in HepG2 cells in response to treatment with
methanol extracts of the T. indica fruit pulp. The concen-
tration of the methanol extracts of the T. indica fruit pulp
that reduced cell viability by 50% (IC50) was also calculated
from the plot.
Treatment of HepG2 cells with methanol extracts
of T. indica fruit pulp
Conﬂuent HepG2 cells maintained in DMEM were treated
with methanol extracts at 300 lg/ml, a non-toxic concen-
tration determined from the MTT assay. The cells were
then incubated at 37C for 24 h. As a control, cells were
incubated in the absence of the methanol extracts. After
24 h, cells were trypsinized and then precipitated by cen-
trifugation at 1,300 rpm for 5 min. Cells were washed with
PBS twice before total cellular RNA (tcRNA) was
extracted from the cells.
Total cellular RNA preparation from the control
and treated HepG2 cells
tcRNA from both untreated (control) and T. indica-treated
HepG2 cells was isolated and then puriﬁed using RNAEasy
kit (Qiagen) according to the manufacturer’s instructions.
Brieﬂy, the cells were lysed with guanidine thiocyanate-
containing buffer (RLT buffer) followed by homogeniza-
tion with a QIAshredder. Ethanol (75%) was then added to
the mixture, and the mixture was then loaded into RNA spin
columns. Following this, the columns were washed with
RW1 and RPE buffers that were supplied by the manufac-
turer. After washing with a reduced volume of buffer RW1,
the RNA was treated with DNase I using RNase-free DNase
Set (Qiagen) while bound to the RNAEasy membrane. The
DNase I was removed by a second wash with buffer RW1.
Then, washing with buffer RPE and elution of RNA were
then performed. In the ﬁnal step, the tcRNA was eluted
using RNase-free water into collection tubes. The quality of
the tcRNA was estimated by measuring the absorbance ratio
of 260–280 nm. Values above 1.8 indicate that the tcRNA is
of good quality. The integrity of the tcRNA was also ana-
lysed using denaturing gel electrophoresis. The integrity of
the tcRNA is indicated by the presence of two distinct bands
corresponding to the ribosomal 28S and 18S subunits, with
the intensity of the larger 28S band approximately twice
than that of the smaller 18S band.
Preparation of the sense strand DNA for microarray
gene expression analysis
Gene expression analysis was performed on the Affymetrix
Human Gene 1.0 S.T (sense target) arrays according to the
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col (Affymetrix). Brieﬂy, the tcRNA (100 ng) isolated
from the untreated (control) and the T. indica-treated
HepG2 cells was ﬁrst converted to single-stranded sense
strand DNA (cDNA) in two cycles using the whole tran-
script (WT) cDNA synthesis, ampliﬁcation kit and sample
clean-up module. In the ﬁrst cycle, the tcRNA was con-
verted to double-stranded cDNA using random hexamers
tagged with a T7 promoter sequence. Each strand of the
double-stranded cDNA was then used as a template to
synthesize antisense RNA (cRNA). In the second cycle, the
cRNA was reversed transcribed into sense strand DNA in
the presence of random hexamers (3 lg/ml) and dNTPs
mix containing dUTP (10 mM).
Sense strand DNA labelling and hybridization
to the Affymetrix Human Gene 1.0 S.T arrays
The sense strand DNA was cleaned up using the sample
clean-up kit and then cleaved into small fragments using a
mixture of UDP and apurinic/apyrimidinic endonuclease 1
or APE1. The fragmented sense strand DNA was then
end-labelled through a terminal transferase reaction that
incorporates biotinylated dideoxynucleotides using the
WT terminal labelling kit. The fragmented, biotinylated
sense strand DNA (5.5 lg) was then hybridized to the
Affymetrix Human Gene 1.0 S.T array at 45C for 16 h
in a hybridization Oven 640. After hybridization, the
arrays were stained and then washed in the Affymetrix
Fluidics Station 450 under standard conditions. The
stained arrays were then scanned at 532 nm using an
Affymetrix GeneChip Scanner 3000, and CEL ﬁles for
each array were generated using the Affymetrix Gene-
Chip
 Operating Software (GCOS). The data were sub-
jected to normalization, background correction and data
summarization using Affymetrix Expression Console
software.
Microarray data normalization and analysis
The CEL ﬁles were then converted to text ﬁles and
exported to Partek Genomic Suite software to get the whole
list of up-regulated and down-regulated genes. The whole
gene lists generated were then normalized by ﬁltering out
probeset IDs that did not have any annotation in the Partek
software, using the Netaffx Analysis Center software. The
gene sets were then subjected to a one-way analysis of
variance (ANOVA) in the Partek Genomic software to
determine signiﬁcantly expressed sets of genes, which was
set according to P value less than 0.05 (P\0.05). Sig-
niﬁcantly expressed genes were then re-ﬁltered to include
only those with fold change difference of equal to or
greater than 1.5.
Biological interpretation: gene ontology (GO)
Additional information on the biological functions of the
genes (genes products) that were signiﬁcantly regulated
(P\0.05) with a fold change which was equal to or
greater than 1.5 was determined using the Gene Ontology
Enrichment tool in the Partek Genomic Suite Software.
Validation of the microarray data using
semi-quantitative reverse transcription polymerase
chain reaction (RT–PCR)
The microarray data were validated using semi-quantitative
reverse transcription PCR (RT–PCR) as follows: tcRNA
(2 lg) from control and T. indica-treated cells were
reverse-transcribed to cDNA in a ﬁnal volume of 20 ll
containing a mixture of ﬁrst strand buffer (1X), random
hexamers (25 ng/ll), dNTP mix (0.5 mM), dithiothreitol
(DTT) (0.1 M) and superscript II reverse transcriptase
(10 units). The mixture was then incubated at 42C for
50 min followed by inactivation at 70C for 15 min. The
cDNA was then used as templates for PCR ampliﬁcation of
selected up-regulated and down-regulated genes using
primer pairs listed in Table 1. A PCR mixture containing
cDNA (2000 ng), PCR buffer (1 X), 50 and 30 primers for
GADPH and the selected genes of interest (1 lM), dNTPs
(10 mM), DMSO (10% v/v) and Taq DNA polymerase
(5 units) were prepared to a ﬁnal volume of 50 ll with
sterile distilled water (Sigma). PCR ampliﬁcation was
carried out in a thermal cycler (Biometra) with initial DNA
denaturation at 95C for 3 min followed by 35 cycles of
denaturation at 94C for 5 s, annealing of primers to the
cDNA templates at 55C for 1 min and DNA extension/
elongation at 72C for 3 min. The ﬁnal DNA extension was
done at 72C for 10 min. The PCR products were then
separated through electrophoresis on a 2% agarose gel
stained with 2 lg/ml ethidium bromide. The separated
bands were visualized using a UV transilluminator, and the
images were captured using a Canon CCD camera (BioRad
Gel Doc 1000/2000). The intensity of the bands that
corresponded to the amount of the PCR products of the
selected regulated genes was then quantitated using
Quantity One software (BioRad). Scanned values were
expressed in arbitrary unit, and the expression of the
selected genes relative to that of a housekeeping gene
GADPH was then determined.
Validation of the microarray data using real-time
RT–PCR
Validation of the microarray data using quantitative real-
time PCR (qRT–PCR) was carried out in a StepOne
TM
Real-Time PCR System (Applied BioSystem). The same
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down-regulated genes as well as a housekeeping gene,
GADPH, as listed in Table 1 were used. The PCR ampli-
ﬁcation was performed in 0.2 ml MicroAmp
 Optical
8-tube strips in a ﬁnal volume of 20 ll containing a mix-
ture of cDNA (30 ng), reverse and forward primers
(1 lM), pre-prepared Power SYBR
 Green PCR master
mix containing SYBR Green 1 dye, AmpliTaq Gold

DNA Polymerase dNTPs, dUTP, Passive Reference 1 and
optimized buffer components. The PCR parameters con-
sisted of 40 cycles of ampliﬁcation with initial denaturation
at 95C for 15 s, annealing of primers and elongation of the
newly synthesized strands at 60C for 60 s. The PCR
mixture was initially held for 10 min at 95C for AmpliTaq
Gold
 DNA polymerase activation. The comparative CT
method (DDCT) was chosen for the relative quantitation of
gene expression. Each sample type was run in triplicate.
mRNA levels of the selected genes were normalized
against GADPH mRNA.
Results
MTT cell proliferation assay
The viability of HepG2 cells (%) in response to different
concentrations of the methanol extracts of the T. indica
fruit pulp is presented as a log plot in Fig. 1a. The plot
shows a concentration-dependent decrease in cell viability
with increasing concentrations of the methanol extracts of
the T. indica fruit pulp. Cell viability was maintained above
80% even at a concentration of 1,000 lg/ml. The IC50 was
found to be 4.57 mg/ml. Figure 1b shows the pictures of
the cells viewed under light microscope, when the cells
were treated with 300 lg/ml and 4.57 mg/ml of the
methanolic extracts. In this study, we investigated the
effects of methanol extracts of the T. indica fruit pulp on
gene expression patterns in cultured human HepG2 cells at
a concentration of 300 lg/ml where cell viability was still
above 90%.
Normalization and visualization of microarray data
Microarray data were initially visualized using a principal
components analysis (PCA) plot (Fig. 2). The data from the
control group (n = 3) were shown in blue, whereas those
in the treated group (n = 3) were indicated in red. Each
ball represents gene expression data generated from a
sample that was applied on a gene chip. Figure 2a shows
the data that were generated from the three biological
replicates. From the plot, sample outliers were not detected
both in the control and in treated group. The control group
is also distinguishably separated from those of the treated
samples. Each biological replicate comprising a control
and a treated sample was also analysed on a different date
(scan date), and the results are illustrated in Fig. 2b. It
clearly shows that when analysed together, the control and
the sample in each replicate are always grouped together.
Figure 3 shows hierarchical clustering of genes in
HepG2 cells in response to treatment with methanol
extracts of the T. indica fruit pulp. Each lane represents an
array. Up-regulated genes in treated samples were shown in
orange, and down-regulated genes were shown in green.
The pattern of the gene expression was similar in the
biological replicates. In response to fruit pulp extracts of
300 lg/ml, 827 genes were signiﬁcantly down-regulated,
and a further 674 genes were signiﬁcantly up-regulated.
Amongst the signiﬁcantly up-regulated genes were MT1M,
MT1F, MT1X, GSTA1, GSTA2 and GST02 (Table 2). In
addition, APOA4, APOA5 and ABCG5 were also up-regu-
lated. Genes that were signiﬁcantly down-regulated include
PDE3A, PTTG1, CYP1A1, IFIT1 and MTTP (Table 2).
Table 1 Primer sequences for
the selected genes used for
validation of the microarray
data using semi-quantitative
RT–PCR and real-time
RT–PCR
Gene Primer sequence Product
size
(bp)
Glyceraldehyde-3-phosphate
dehydrogenase (GADPH)
(NM_002046)
Forward: 50-TGCCTCCTGCACCACCAACTGC-30
Reverse: 50-AATGCCAGCCCCAGCGTCAAAG-30
457
Phosphodiesterase 3A
(PDE3A) (NM_000921)
Forward: 50-GAACAGATGACACTGCTCAAGTT-30
Reverse: 50-GAGCAAGAATTGGTTTGTCCAG-30
180
Interferon-induced protein
with tetratricopeptide
repeats (IFIT1) (NM_001548)
Forward: 50-AGAACGGCTGCCTAATTTACAG-30
Reverse: 50-GCTCCAGACTATCCTTGACCTG-30
73
Glutathione S-transferase
A1 (GSTA1) (NM_145740)
Forward: 50-AGCCGGGCTGACATTCATCT-30
Reverse: 50-TGGCCTCCATGACTGCGTTA-30
230
Microsomal triglyceride
transfer protein (MTTP)
(NM_000253)
Forward: 50-CGTTCGGCATCTACTTACAGC-30
Reverse: 50-GTTCTCCTCCCCCTCGTCAG-30
180
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cycles CCNG1, CCNG2, CCNA2, CCNB1, CCNB2 and
CDC2 were also signiﬁcantly down-regulated.
Gene ontology: biological process
Gene ontology analysis of the differentially expressed
genes in HepG2 cells in response to treatment with the
methanol extracts of the T. indica fruit pulp is shown in
Figs. 4 and 5. In Fig. 4, genes (and subsequently their gene
products) were categorized into their participations in
general metabolisms. It was found that 60 genes that are
related to reactive oxygen species were up-regulated,
whereas 13 were down-regulated. In addition, 95 genes that
are involved in lipid metabolism were down-regulated, and
another 62 were up-regulated. Figure 5 shows the number
of signiﬁcantly regulated genes that are categorized
according to their roles in major biological processes (a),
molecular functions (b) and major cellular components (c).
The green bars represent the up-regulated genes, and the
purple bars depict the down-regulated genes.
Validation of the microarray data
Semi-quantitative RT–PCR analysis was performed on
selected signiﬁcantly regulated genes as follows: PDE3A,
GSTA1 and MTTP (Fig. 6). The sizes of the PCR products
that corresponded to the selected genes were 180, 230 and
180 bps, respectively. The PCR product for the house-
keeping gene, GADPH, which is 457 bp, is shown by the
arrow. The relative expression of the PDE3A, GSTA and
MTTP genes to that of the housekeeping gene were -0.69-,
1.401- and -0.439-fold, respectively.
The expression of the selected genes PDE3A, GSTA1,
CYP1A1 and MTTP as well as the interferon-induced
protein (IFIT1) relative to that of GADPH was also
quantitated using real-time RT–PCR. As shown in Fig. 7,
the pattern of expression of the genes analysed using
microarray technology was similar to that of the real-time
RT–PCR. The MTTP gene was down-regulated by -1.25-
fold in real-time RT–PCR compared with -1.96-fold in
microarray. PDE3A gene was down-regulated by about
-5.06-fold in RT–PCR when compared with -5.10 in
microarray analysis. CYP1A1 gene was also shown to be
down-regulated when analysed using both RT–PCR and
microarray methods by -2.73- and -3.61-fold, respec-
tively. GSTA1 was up-regulated by 1.54-fold in RT–PCR
analysis compared with 2.8-fold in microarray. In addition,
IFIT1 was up-regulated by fourfold in RT–PCR compared
with 6.41-fold in microarray. All data were normalized to
the reference gene, GAPDH. The expression patterns
obtained with semi-quantitative RT–PCR and real-time
RT–PCR were consistent with the microarray results.
Discussion
The MTT assay is a rapid colorimetric assay developed by
Mosman [28] and had since been widely used to measure
cell viability/proliferation in living cells [2, 5, 15]. In this
study, the methanol extracts of the T. indica fruit pulp were
shown to have an IC50 of 4.57 mg/ml. For the microarray
Fig. 1 a A log plot of concentrations of the T. indica fruit pulp
extracts (lg/ml) versus percentage (%) of HepG2 cells viability. From
the log10 plot, the IC50 was found to be 4.57 mg/ml. b Examination
under light microscope of morphological changes in HepG2 cells
incubated for 48 h in the presence of 300 lg/ml and 4.57 mg/ml of
the T. indica fruit pulp extracts
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where cell viability was still above 90%. We decided to use
a low concentration of the extracts instead of the usual IC50
concentration, because it is known that dietary antioxidants
are present in circulation in small amount because they are
either poorly absorbed from the intestine or once absorbed
they are quickly metabolized [18, 46]. At this low con-
centration, we found that the methanol extracts of the
T. indica fruit pulp were able to signiﬁcantly regulate a total
of 1501 genes (P\0.05) with a fold change of at least 1.5.
Amongst the signiﬁcantly up-regulated genes were those
that code for the metallothioneins (MTs), MT1M, MT1F,
MT1X and glutathione S-transferases (GSTs) namely
GSTA1, GSTA2 and GSTO2.MTs and GSTs have protective
roles over heavy metals such as cadmium [8] and oxidative
DNA, protein and lipid damage [6, 11]. In this study, only
genes encoding MT-1 but not the other two isoforms, MT-2
and MT-3, were induced by low concentration of the
T. indica fruit pulp extracts. In addition, GSTs are involved
in the detoxiﬁcation of xenobiotics such as toxins and
carcinogens [13, 15] and regulate cellular stress response to
the formation of reactive oxygen species through the JNK-
associated apoptosis [39]. Omega class GSTs have dehy-
droascorbate reductase and thioltransferase activities and
also catalyse the reduction of monomethylarsonate, an
intermediate in the pathway of arsenic biotransformation.
Other diverse actions of human GSTO1-1 include modu-
lation of ryanodine receptors and interaction with cytokine
release inhibitory drugs. Glutathione S-transferase omega 1
and omega 2 (GSTO1 and GSTO2) catalyse monomethyl
arsenate reduction during arsenic biotransformation [29].
Diseases of the cardiovascular system are the most
common cause of death in developed countries. It has
been established that hyperlipidaemia including high
cholesterol levels in blood represents a major risk factor
for the premature development of atherosclerosis and its
Fig. 2 A principal components
analysis (PCA) plot of HepG2
cells grown in the presence and
absence of extracts of the
T. indica fruit pulp showing
biological replicates (n = 3) of
control and treated samples.
Arrays for the control group
were in blue, and those for the
treated group were in red. The
data are clustered by treatment
(a) and scan date (b). Each ball
represents an array or a sample
Control 
Treated 
Gene expression 
Array 
Array 
Array
Array 
Array
Array
Fig. 3 Hierarchical cluster
analysis of genes showing the
differential expression of genes
in HepG2 cells in response to
the treatment with methanol
extracts of T. indica fruit pulp
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123cardiovascular complications. Presently, statin, which is
an inhibitor of HMGCoA reductase, is widely used to
decrease plasma LDL and is able to reduce cardiovascular
events by 20–40% [42]. Patients who cannot tolerate or
respond poorly to statin are given other hypolipidaemic
therapies such as ﬁbrates and nicotinic acid. Scientists are
now tapping into the rich biodiversity of the world to look
for functional foods that can reduce cholesterol and lipid
levels and are as potent, well-tolerated, cheaper, safer
alternatives to the currently marketed drugs.
The extracts of the T. indica fruit pulp have the potential
to be used as lipid-lowering agents. An earlier study by
Table 2 A list of selected
signiﬁcantly up-regulated and
down-regulated genes in HepG2
cells treated with methanolic
extracts of T. indica fruit pulp
that may be related to stress
response (A), lipid metabolic
processes (B) and others (C)
Details of the GenBank
accession number, name of the
gene and its respective protein
and fold change difference
between treated and non-treated
cells are included
Genebank ID Protein (gene name) Fold change (treated
vs. untreated)
Stress response
NM_176870 Metallothionein 1 M (MT1M) 5.21
NM_005949 Metallothionein 1F (MT1F) 2.35
NM_005952 Metallothionein 1X (MT1X) 1.68
NM_145740 Glutathione S-transferases (GSTA1) 2.80
NM_000846 Glutathione S-transferases (GSTA2) 1.60
NM_183239 Glutathione S-transferases (GSTO2) 1.73
Lipid metabolic process
NM_000482 Apolipoprotein A-IV (APOA4) 2.31
NM_052968 Apolipoprotein A-V (APOA5) 1.90
NM_022436 ATP-binding cassette, subfamily G (WHITE), member 5 (ABCG5) 1.84
NM_000253 Microsomal triglyceride transfer protein (MTTP) -1.80
Others
NM_000921 Phosphodiesterase 3A, cGMP-inhibited (PDE3A) -5.10
NM_000499 Cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) -3.61
NM_004590 Chemokine (C–C motif) ligand 16 (CCL16) -4.36
NM_004219 Pituitary tumour-transforming 1 (PTTG1) -2.93
NM_199246 Cyclin G1 (CCNG1) -2.31
NM_004701 Cyclin B2 (CCNB2) -2.24
NM_004354 Cyclin G2 (CCNG2) -1.97
NM_001237 Cyclin A2 (CCNA2) -1.93
NM_001786 Cell division cycle 2, G1 to S and G2 to M (CDC2) -1.85
NM_031966 Cyclin B1 (CCNB1) -1.78
Fig. 4 An analysis of the
involvement of the differentially
expressed genes in HepG2 cells
in response to treatment with the
methanol extracts of the
T. indica fruit pulp in general
metabolisms. The purple and
green bars represent the number
of down-regulated and
up-regulated genes,
respectively. Amongst the
down-regulated genes are those
involved in cholesterol
synthesis and lipoprotein
metabolism
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123Martinello et al. [26] showed that the extracts of the
T. indica fruit pulp were able to decrease the levels of
serum cholesterol and triglycerides in hypercholesterolae-
mic hamsters. The molecular mechanism of the lipid-
lowering activity of the fruit extracts is, however, still
unknown. Our microarray analysis did not detect changes
in the expression of the HMGCoA reductase gene, sug-
gesting that the lipid-lowering activity is not through the
inhibition of cholesterol biosynthesis. Our microarray data
showed that amongst others, three genes that critically
regulate lipid metabolism were differentially expressed:
APOA4, APOA5, ABCG5 and MTTP.
Apoliporotein A-V (ApoA-V) that is coded by APOA5
gene plays a vital role in the regulation of TG metabolism
[43]. ApoA-V is thought to reduce TG levels by activating
lipoprotein lipase (LPL), the enzyme that is responsible
in catabolizing TG-rich lipoproteins, chylomicrons and
VLDL, hence improving the clearance of these lipoproteins
Fig. 5 Gene ontology analysis. Forest plots showing the categoriza-
tion of the signiﬁcantly regulated genes (P\0.05; fold change more
or equal to 1.5) according to their roles in major biological processes
(a), molecular functions (b) and major cellular components (c). The
green bars represent the up-regulated genes, and the purple bars
depict the down-regulated genes
Fig. 6 Validation of the microarray data using semi-quantitative
RT–PCR. A few genes that were regulated in HepG2 cells in response
to treatment with extracts of the T. indica fruit pulp were selected
namely PDE3A, GSTA1 and MTTP genes. The expression of the
selected genes relative to that of a housekeeping gene, GADPH, was
calculated and was expressed as a fold change. The PCR products for
the housekeeping gene, GADPH, are shown by the red arrow. The
intensity of the bands was quantitated using a densitometer scanner
338 Genes Nutr (2010) 5:331–341
123from blood. Mutations in the APOA5 gene have been
shown to cause hypertriglyceridaemia [35]. In our study,
we found that in the methanol extract-treated HepG2 cells,
APOA5 gene was up-regulated by 1.9-fold. This could be
contributed by procyanidin, a phenolic compound found in
grape seed that was able to lower TG levels in rats, up-
regulate apoA5 gene expression in mouse liver [12] and
was shown to also be present in the T. indica fruit pulp
[44].
APOA4 gene codes for the apolipoprotein A-IV (ApoA-
IV) which is like cholecystokinin (CCK), a known gas-
trointestinal satiety signal proteins whose synthesis and
secretion from the gut are stimulated by fat absorption [24].
Apart from the intestine, apoA-IV is also synthesized by
the hypothalamus, and the gene has also been shown to be
expressed in the liver [23]. In human hepatoma HepG2
cells, APOA4 mRNA was up-regulated when cells were
treated with liver X receptors (LXR) agonists. LXRs are
oxysterol receptors that can mediate cholesterol homeo-
stasis. Treatment of C57B6 mice with a synthetic LXR
agonist, T0901317, resulted in signiﬁcant increases in
plasma apoA-IV that was associated with an increase in
high-density lipoprotein. Examination of both intestinal
and liver apo A-IV mRNA revealed speciﬁc increases in
liver mRNA only [23]. ApoA-IV had also been shown to
be a potent endogenous antioxidant that inhibits lipid per-
oxidation [14, 36].
In this study, the gene encoding an ATP-binding cassette
sterol transporter, ABCG5, was also up-regulated by the
methanol extracts of the T. indica fruit pulp. ABCG5 has
been shown to be regulated in the liver and intestine by the
LXRs [38, 48]. An overexpression of ABCG5 was found to
promote cholesterol excretion through bile and reduce
absorption of dietary cholesterol [48]. In addition, muta-
tions in the ABCG5 gene were implicated in sitosterola-
emia [17, 19, 25], characterized by elevated plasma levels
of plant sterols and cholesterol due to increased absorption
and decreased excretion of the neutral sterols into biles
[3, 4]. The increased circulating levels of these sterols are
associated with the deposition of cholesterol in the skin and
tendons (xanthomas), and in the walls of the coronary
arteries, resulting in premature coronary atherosclerosis.
Peroxisome proliferator-activated receptor alpha
(PPARa) is a key regulator in hepatic lipid metabolism,
and apoA-IV had been identiﬁed as a potential therapeutic
target for dyslipidaemia [30]. Oral administration of
PPARa agonist KRP-101 in dogs caused a decrease in
serum TG accompanied by an increase in serum apoA-IV
levels [30]. In addition, administration of a potent and
selective PPARa agonist, LY570977 L-lysine decreased TG
and increased circulating apoA-V levels in cynomolgus
monkeys [41]. Functional PPAR-binding element in the
promoter of the human APOA5 gene was found in human,
which is somewhat degenerate and non-functional in the
corresponding mouse Apoa5 [34]. APOA5 resides on the
APOAI/CIII/AIV gene cluster on human 11q23 [33]. Gene
coding for the apolipoprotein C-III which is a marker of
TG-rich lipoproteins was up-regulated in this study but at a
lower fold change compared to that of the APOA5 with
APOA5/APOC3 ratio of 1.3.
In our study, we found that the crude extracts from the
T. indica fruit pulp up-regulated the expression of genes
that code for apoA-IV, apo A-V and ABCG5. Since the
methanol extracts up-regulated three genes, we postulated
that there are components in the crude extracts that may act
as PPARalpha agonist which can regulate TG and HDL
levels and may eventually be able to be used as a lipid-
lowering agent. It is postulated that there may be compo-
nents in the extracts that could also regulate cholesterol
homeostasis by increasing the expression of the ABCG5
gene that could promote biliary cholesterol secretion and
reduce dietary cholesterol absorption which could poten-
tially be used to reduce TG levels in blood and help to
prevent coronary heart disease.
We also found that the crude extract down-regulated the
expression of the MTTP gene that codes for microsomal
Fig. 7 Validation of the microarray data using real-time RT–PCR.
The bar chart shows the gene expression patterns (presented as fold
change) of selected signiﬁcantly regulated genes calculated using
semi-quantitative RT–PCR, real-time RT–PCR and microarray anal-
ysis. The down-regulated genes selected were MTTP, PDE3A and
CYP1A1, while the up-regulated genes are GSTA1 and IFIT1. All
PCR data were normalized to the intensity of GAPDH as a
housekeeping gene. *NQ IFIT1 gene expression was not included
in the semi-quantitative RT-PCR
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123triglyceride transfer protein (MTTP). MTTP is required for
the assembly and secretion of TG-rich lipoproteins from
both enterocytes and hepatocytes. MTTP inhibitor, JTT-
130, had been shown to lower plasma lipid mainly plasma
TG [1]. The inhibition of MTTP gene expression, espe-
cially in the intestine, may subsequently lead to reduction
in the levels of cholesterol in blood.
Other genes that were down-regulated in response to the
extracts of the T. indica pulp were PDE3A, PTTG1 and
CYP1A1. PDE3 is one of the phosphodiesterases (PDEs)
that regulate intracellular concentrations of second mes-
sengers, cAMP and cGMP, by catalysing the hydrolysis of
their 30-50-phosphodiester bond [1]. The PDE3 family
comprises 2 genes, the PDE3A and PDE3B. The PDE3A
has higher afﬁnity towards cAMP than cGMP and is
directly inhibited by cGMP [19]. Known inhibitors of the
PDE3 include cilostamide and milrinone, but these inhib-
itors do not differentiate between PDE3A and PDE3B [3].
The crude extracts of the T. indica fruit pulp suppressed the
expression of only the PDE3A, by 5.1-fold, suggesting that
the extracts contain bioactive compound(s) that is (are)
selective inhibitor(s) of PDE3A.
PTTG1 is an oncogene involved in cell cycle regulation
and sister chromatid separation [31]. High levels of PTTG1
expression have been reported in various tumours including
thyroid, pituitary, lung, colon, oesophagus, ovary and breast
[16, 40, 47]. Studies had shown that nude mice developed
cancer when subcutaneously injected with PTTG1-trans-
fected cells [32]. CYP1A1 is one of the most important
detoxiﬁcation enzymes, but it is also capable of generating
carcinogenic intermediate metabolites from polycyclic
aromatic hydrocarbons [20]. Resveratrol, an antioxidant
widely found in fruits such as grapes, was found to inhibit
the transcription of CYP1A1 in the HepG2 cells supposedly
by preventing the activation of aryl hydrocarbon receptor
[10]. Our microarray results showed that the crude extracts
of the T. indica fruit pulp have the potential application as a
chemotherapeutic agent for the treatment of cancer through
the inhibition of the transcription of CYP1A1 and PTTG1
genes. In addition, a set of genes that are involved in reg-
ulating the cell cycle checkpoints namely the cyclins,
CCNG1, CCNG2, CCNA2, CCNB1, CCNB2 and CDC2
were also signiﬁcantly down-regulated.
In conclusion, low concentration of T. indica fruit pulp
extracts was able to signiﬁcantly regulate a total of 1501
genes. Amongst the up-regulated genes were those that
code for the metallothioneins and glutathione S-transfer-
ases which are well known for their stress response activ-
ities. The extracts may act as hypolipidaemic agents by
regulating the expression of APOA4, APOA5, ABCG5 and
MTTP genes. The fruit pulp extracts also have anti-cancer
potential by regulating genes involved in the cell cycle
checkpoints.
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